Skip to content
10-K/A

Annual Report

Galileo Life Sciences, Inc.

0001471242-14-000255

← back to feed
Filed
Jun 20, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow FY 2012 · Jun 30, 2013 −$58.77K
Operating Cash Flow FY 2012 · Jun 30, 2013 −$430.19K
Stockholders Equity FY 2012 · Jun 30, 2013 −$519.77K
Current Liabilities FY 2012 · Jun 30, 2013 $519.77K
Total Liabilities FY 2012 · Jun 30, 2013 $519.77K
Total Assets FY 2012 · Jun 30, 2013 $0
Net Income FY 2012 · Jun 30, 2013 −$52.6K
Net Income FY 2012 · Jun 30, 2013 −$585.04K
Operating Income FY 2012 · Jun 30, 2013 −$55.22K
Operating Income FY 2012 · Jun 30, 2013 −$587.65K
Gross Profit FY 2012 · Jun 30, 2013 $3.41K
Cost Of Revenue FY 2012 · Jun 30, 2013 $6.1K
Revenue FY 2012 · Jun 30, 2013 $9.51K